RNT Stock Overview
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Private Rented Sector S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł6.20 |
| 52 Week High | zł11.60 |
| 52 Week Low | zł2.00 |
| Beta | 2.36 |
| 1 Month Change | -13.29% |
| 3 Month Change | 179.28% |
| 1 Year Change | -11.43% |
| 3 Year Change | 174.34% |
| 5 Year Change | 376.92% |
| Change since IPO | -96.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNT | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -4.6% | -3.8% | -0.7% |
| 1Y | -11.4% | -9.7% | 24.8% |
Return vs Industry: RNT underperformed the Polish Medical Equipment industry which returned -9.7% over the past year.
Return vs Market: RNT underperformed the Polish Market which returned 24.8% over the past year.
Price Volatility
| RNT volatility | |
|---|---|
| RNT Average Weekly Movement | 34.1% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 10.0% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: RNT's share price has been volatile over the past 3 months.
Volatility Over Time: RNT's weekly volatility has increased from 23% to 34% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jakuba Suchanek | www.medical-isotope.com |
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland. The company offers Technetium-99m, a medical isotope for deployment using standard research and commercial reactors. The company was formerly known as Perma-Fix Medical S.A. and changed its name to Private Rented Sector S.A. in March 2023.
Private Rented Sector S.A. Fundamentals Summary
| RNT fundamental statistics | |
|---|---|
| Market cap | zł8.19m |
| Earnings (TTM) | zł27.21k |
| Revenue (TTM) | zł200.00k |
301.2x
P/E Ratio41.0x
P/S RatioIs RNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNT income statement (TTM) | |
|---|---|
| Revenue | zł200.00k |
| Cost of Revenue | zł0 |
| Gross Profit | zł200.00k |
| Other Expenses | zł172.80k |
| Earnings | zł27.21k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 0.021 |
| Gross Margin | 100.00% |
| Net Profit Margin | 13.60% |
| Debt/Equity Ratio | 0% |
How did RNT perform over the long term?
See historical performance and comparison